“`html
The John Hancock Multifactor Mid Cap ETF (JHMM) has an implied analyst target price of $71.72 per unit, representing a 10.40% upside from its recent trading price of $64.96. This estimate is based on an analysis of underlying holdings and their average 12-month forward target prices.
Key underlying stocks contributing to this estimation include Axsome Therapeutics Inc (AXSM), which shows a 47.94% upside from its current price of $118.63 to an average target of $175.50; Mobileye Global Inc (MBLY), demonstrating a 31.12% upside from $14.59 to $19.13; and Waystar Holding Corp (WAY), with a projected increase of 27.60% from $38.58 to an average target of $49.23.
“`
